- NZ$9.80m
- NZ$9.42m
- NZ$1.51m
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising
Brief: Rua Bioscience Says Sales For Q1 FY26 Are A Record
Brief: Rua Bioscience Secured A Total Of NZ$1.2 Mln In New Funding
New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group
Brief: Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings
Brief: Rua Bioscience Says Up To NZ$2 Million Additional Working Capital
Brief: Rua Bioscience Posts HY Net Loss Before Tax Of NZ$1.8 Million
Brief: Rua Bioscience Posts HY Net Loss NZD 1.8 Million
Brief: Rua Bioscience Ltd Sees Revenue Over NZ$3Mln By End Of FY25
Brief: Rua Bioscience Announces Rights Offer To Raise Up To NZ$3.1 Mln
Brief: Rua Bioscience Says Not Received Settlement Funds For Sale Of Gisborne Manufacturing Facility
Brief: Rua Bioscience Expect Revenue From Customers In Fy25 Will Be Significantly Higher
Brief: Rua Bioscience Posts FY Revenue NZD 320 Thousand
Brief: Rua Bioscience Announces Sales Of Gisborne Manufacturing Facility
Brief: Rua Bioscience Partners With Alphafarma For Supply To Germany
Brief: Rua Bioscience Signs Agreement With Cannprisma